Priveterra Acquisition Corp. (NASDAQ:PMGM) announced this afternoon that its special meeting, intended to approve its combination with AEON Biopharma, has been adjourned for the seventh consecutive time.
Given the SPAC’s completion deadline of August 11, it is unlikely that this will be the last adjournment we will see for this completion vote.
Initially scheduled for noon today, the meeting has now been pushed back until June 30 at 4:00 p.m. Priveterra continues to reiterate its commitment to utilizing the extended time during the postponement to further engage with its shareholders.
The deal with AEON Biopharma includes a $40 million minimum cash condition, half of which has already been secured through a $20 million commitment from existing AEON investors at $7 per share. But, Priveterra’s trust, originally totaling $276 million, has been reduced to about $20.3 million after seeing 92.7% of shares redeemed in earlier votes.
Priveterra inked its $201.8 million business combination with drug developer AEON on December 13. Irvine, California-based AEON is working on an injection-based migraine treatment to compete with Botox for chronic and frequent sufferers.
1RT (NASDAQ:ONCHU) has filed for a $150 million SPAC with confident terms in a market that has been recently much more welcoming to SPAC issuance. The new SPAC is including 1/4 warrants in its units, which is the slimmest warrant coverage offered by a newly-filed SPAC since Cohen Circle II (NASDAQ:CCIIU) put out its own...
At the SPAC of Dawn This week, the market has taken on better-than-expected inflation news and SPACs continue to see old friends leaning toward listing in the traditional way. This time it is crypto exchange Bullish which is reportedly seeking an IPO three years after canceling its combination with a SPAC. Bullish was initially engaged...
EQV Ventures II (NYSE:EVACU) has filed for a $350 million SPAC aiming to give its team a second vehicle to pursue targets within hopefully a more receptive market environment than its first. The team’s first SPAC, EQV I (NYSE:EQV), broke price on its debut on August 7, 2024, finishing with a one-day VWAP of $9.9452...
HCM III (NASDAQ:HCMAU) has filed for a $220 million SPAC to mount a broad search for a target with a team that had been steadily building a track record of success. The new SPAC offers investors a 1/3 warrant in each unit, but no overfunding of its trust as the team has done in its...
At the SPAC of Dawn Although the past month has been busy in many forms of SPAC activity, it has so far marked a slowdown from April in terms of new deal announcements with three in May and two so far in June. There are several signs that more are on the way, however, including...